Is DaVita Stock Underperforming the S&P 500? DaVita has underperformed the S&P 500 index over the past three months. However, Wall Street analysts are moderately optimistic about its prospects. Barchart · Sep 23
3 Surging Stocks That Don’t Need the AI Boom to Keep Winning DaVita, Franklin Resources, and Archer Daniels Midland have each gained more than 30% year to date in 2026, offering investors diversification away from AI-driven stock market gains. MarketBeat · Sep 21
Are Wall Street Analysts Bullish on DaVita Stock? Though DaVita has outpaced the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects. Barchart · Aug 11
What You Need To Know Ahead of DaVita’s Earnings Release DaVita is entering earnings with strong momentum as investors look for another quarter of solid execution. Barchart · Jul 15
Akebia Therapeutics Sees Vafseo Uptake Rising as Access and Pipeline Milestones Near Akebia Therapeutics (NASDAQ:AKBA) outlined its commercial priorities for Vafseo, the expected evolution of reimbursement after the TDAPA period and several renal-disease pipeline programs during a fireside chat at the Jefferies 2026 Global Healthcare Conference. Erik, Akebia’s chief financial offic MarketBeat · Jun 5
What Are Wall Street Analysts' Target Price for DaVita Stock? DaVita has outpaced the broader market over the past year, with Wall Street analysts maintaining a cautiously optimistic outlook on the stock’s long-term prospects. Barchart · May 13
What to Expect From DaVita's Next Quarterly Earnings Report DaVita is set to announce its first-quarter results in May, with analysts forecasting a double-digit increase in the company’s bottom-line figure. Barchart · Apr 22
How Berkshire Hathaway Performed During Buffett's Final Quarter Buffett’s final quarter saw a 25% drop in net income, but his final portfolio moves—including increased positions in Chubb and Chevron—have proven prescient. MarketBeat · Mar 3
Berkshire’s New CEO Just Offloaded DaVita Stocks: Should You Sell Yours Too? For the first time since 1965, Berkshire Hathaway has made a major trade under the direction of someone other than former CEO Warren Buffett. The conglomerate recently sold roughly 1.65 million shares... GOBankingRates · Feb 18
DaVita Stock: Is Wall Street Bullish or Bearish? Are Wall Street analysts bullish or bearish on DaVita’s stock after its fourth-quarter earnings? Barchart · Feb 9
Hedge Funds Are Shorting This Classic Warren Buffett Stock. Should You Sell Shares Now? Hedge funds are betting against DaVita, but low valuations and steady cash flow suggest this Buffett stock may be bruised, not broken. Barchart · Jan 16
Here's What to Expect From DaVita's Next Earnings Report DaVita is set to announce its fourth-quarter results soon, with analysts forecasting a double-digit increase in the company’s bottom-line figure. Barchart · Jan 15
Behind Berkshire’s Curtain: Is Greg Abel Preparing to Cut Davita Loose? Davita hit its 23rd new 52-week low on Tuesday. Its stock is now within a few dollars of trading in double digits. That’s not a good thing, given that its share price was nearly $180 a year ago. Barchart · Jan 14
Is DaVita Stock Underperforming the Dow? As DaVita has underperformed relative to the Dow over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects. Barchart · Dec 15, 2025
inkl · Dec 2, 2025 The Biggest Cybersecurity Threats to Watch Out For In 2026 This year, more than eight ransomware attacks occurred, targeting major companies such as Ingram, Microsoft, Volvo, and DaVita. In 2026, with the aid of AI and AI Agents, these attacks will likely see a spike like never before.
Barchart · Nov 10, 2025 DaVita Stock: Analyst Estimates & Ratings DaVita has considerably underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.
International Business Times UK · Oct 30, 2025 Buffett's Berkshire Hathaway Sells 401K DaVita Shares Two Days Before Q3 Earnings Decline Warren Buffett's Berkshire Hathaway sold over 401,000 shares of healthcare firm DaVita days before its stock price fell following lower Q3 earnings.
Barchart · Sep 23, 2025 Is DaVita Stock Underperforming the Nasdaq? As DaVita has considerably underperformed the Nasdaq recently, analysts remain cautious about the stock’s prospects.
Benzinga · Aug 22, 2025 What's Going With Dialysis Firm DaVita Stock On Friday? The U.S. health department's website reported that a ransomware attack between March and April against dialysis provider DaVita Inc. (NYSE:DVA) exposed the personal data of 2.7 million people.
TechRadar · Aug 6, 2025 Huge healthcare breach sees nearly a million patients hit following DaVita ransomware attack - make sure you're safe Healthcare giant DaVita hit by Interlock attack, and warns patients to remain vigilant.
Tom’s Guide · Aug 5, 2025 Over 900,000 hit in massive healthcare data breach — names, addresses and Social Security numbers exposed online DaVita fell victim to a cyberattack back in March of this year during which time hackers gained unauthorized access to its servers.
Benzinga · Aug 5, 2025 Warren Buffett's Berkshire Hathaway Offloads $230 Million In DaVita Stock Ahead Of Q2 Earnings Warren Buffett’s Berkshire Hathaway Inc. (NYSE:BRK) (NYSE:BRK) has sold off a significant portion of its holdings in DaVita Inc. (NYSE:DVA), a leading dialysis service provider, just before the latter’s Q2 earnings report.
GOBankingRates · Jul 31, 2025 7 Stocks Warren Buffet Has Sold So Far in 2025 If Buffett is unloading some stocks, it pays to take a closer look at their fundamentals. Here's a quick look at the stocks that he's been selling in 2025.
Barchart · Jul 16, 2025 DaVita’s Quarterly Earnings Preview: What You Need to Know DaVita is expected to unveil its second-quarter results in the upcoming month, and analysts expect a single-digit rise in its profitability.
Barchart · Jun 24, 2025 Is DaVita Stock Underperforming the S&P 500? DaVita’s performance over the past year has fallen short of the broader S&P 500 Index, prompting a neutral outlook from analysts regarding its future prospects.